| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Georgia B Vogelsang | |
| Meghan A Higman | |||
| P2860 | cites work | Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease | Q33333428 |
| Development of a prognostic model for grading chronic graft-versus-host disease | Q33336179 | ||
| Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone | Q33342878 | ||
| Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease | Q33349156 | ||
| The management of chronic graft-versus-host disease | Q33488108 | ||
| Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients | Q33503131 | ||
| How I treat chronic graft-versus-host disease | Q34164471 | ||
| Chronic graft-versus-host disease: clinical manifestation and therapy | Q34339695 | ||
| Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease | Q34487403 | ||
| A systematic approach to hepatic complications in hematopoietic stem cell transplantation | Q34619726 | ||
| Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants | Q35180225 | ||
| Quality of life following bone marrow transplantation: findings from a multicentre study | Q36081016 | ||
| Chronic graft-versus-host disease treated with UVB phototherapy | Q39442194 | ||
| Weight loss and malnutrition in patients with chronic graft-versus-host disease | Q40658268 | ||
| Health, functional status, and employment of adult survivors of bone marrow transplantation | Q41872205 | ||
| Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver | Q42609313 | ||
| Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial | Q43423459 | ||
| A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease. | Q43539744 | ||
| Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease | Q43547331 | ||
| Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. | Q43591859 | ||
| Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease | Q43636158 | ||
| Chronic graft-versus-host disease after allogeneic blood stem cell transplantation | Q43727815 | ||
| A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease | Q43773685 | ||
| CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr | Q43806486 | ||
| Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation | Q44049737 | ||
| APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease | Q44241989 | ||
| Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias | Q44329635 | ||
| Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response | Q44417159 | ||
| Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell—depleted grafts from matched unrelated donors: A dose-finding study | Q44947826 | ||
| A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation. | Q47622854 | ||
| Optimistic expectations and survival after hematopoietic stem cell transplantation | Q47821844 | ||
| Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. | Q50856033 | ||
| Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. | Q50974802 | ||
| Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion. | Q51350303 | ||
| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. | Q53313339 | ||
| Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. | Q53488297 | ||
| Quality of life in 244 recipients of allogeneic bone marrow transplantation. | Q53512272 | ||
| Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. | Q53596235 | ||
| Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
| Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. | Q54732493 | ||
| Treatment of chronic GVHD | Q59094234 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chronic graft versus host disease | Q111329725 |
| P304 | page(s) | 435-454 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Chronic graft versus host disease. | |
| P478 | volume | 125 |
| Q51981153 | A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malign |
| Q35748144 | A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials |
| Q36141721 | Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease |
| Q37930715 | Acute graft-versus-host disease following hematopoietic stem-cell transplantation |
| Q36623642 | Addressing parenting concerns of bone marrow transplant patients: opening (and closing) Pandora's box. |
| Q36522959 | Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome |
| Q33857680 | Chronic graft-versus-host disease (GVHD) in children. |
| Q40279320 | Chronic graft-versus-host disease after liver transplantation: a case report |
| Q81773135 | Chronic graft-versus-host disease-like autoimmune disorders spontaneously occurred in rats with neonatal thymus atrophy |
| Q39763917 | Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. |
| Q39437352 | Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. |
| Q81456367 | Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT |
| Q40429162 | Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood |
| Q42194452 | Emergent autoimmunity in graft-versus-host disease |
| Q41657432 | Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease |
| Q34870346 | Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases |
| Q37051405 | Extracorporeal photopheresis in graft-versus-host disease. |
| Q24187102 | Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q24200272 | Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q24202963 | Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q45402377 | Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders |
| Q49951257 | Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease |
| Q36793622 | Graft-versus-host disease |
| Q83661208 | Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease |
| Q34918643 | Guidelines on the use of extracorporeal photopheresis |
| Q86661128 | Hematopoietic stem cell transplantation |
| Q37182608 | High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation |
| Q34135089 | High levels of B-cell activating factor in patients with active chronic graft-versus-host disease |
| Q28281894 | Host-reactive CD8+ memory stem cells in graft-versus-host disease |
| Q34033248 | Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease |
| Q35849241 | Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study |
| Q47928807 | Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. |
| Q91990692 | Late Complications of Allogenic Stem Cells Transplantation in Leukaemia |
| Q41829164 | Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report. |
| Q37163474 | Ocular manifestations of graft-versus-host disease |
| Q57252617 | Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation |
| Q48499689 | Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT. |
| Q34369800 | Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study |
| Q36322963 | Recent advances in haematology and oncology: graft-versus-host disease, classification and treatment of non-Hodgkin's lymphomas, and sentinel-node biopsy in breast cancer |
| Q33396969 | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q37788879 | Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective |
| Q82207888 | Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation |
| Q82662027 | Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation |
| Q35848933 | Rituximab for steroid-refractory chronic graft-versus-host disease |
| Q90289034 | Safety and efficacy of rituximab-based first line treatment of chronic GVHD |
| Q39818849 | Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease–associated dysgammaglobulinemia |
| Q33397272 | Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study |
| Q46070193 | Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil |
| Q50668991 | Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab. |
| Q37682117 | The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation |
| Q37228646 | The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting |
| Q64119777 | The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study |
| Q81939353 | The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT |
| Q44662391 | Treatment of Gastrointestinal Acute Graft-Versus-Host Disease |
| Q46491594 | Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus |
| Q81042779 | Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants |
| Q47352091 | Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease |
Search more.